Rifampin Injection
Mylan Institutional, a Viatris Company · Unavailable · Reason: Demand increase for the drug
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 02/17/2021
- Package NDC
- 67457-445-60
- Generic name
- Rifampin Injection
- Contact info
- 800-796-9526
- Availability
- Unavailable
- Related info
- Estimated recovery: Q4 2026
- Update date
- 09/17/2026
- Dosage form
- Injection
- Presentation
- Rifampin, Injection, 600 mg (NDC 67457-445-60)
- Company name
- Mylan Institutional, a Viatris Company
- Shortage reason
- Demand increase for the drug
- Status
- Current
- Therapeutic category
- Anti-Infective
- Harmonized identifiers (openFDA)
- Application number
- ANDA065421
- Brand name
- RIFAMPIN
- Generic name
- RIFAMPIN
- Manufacturer name
- Mylan Institutional LLC
- Product NDC
- 67457-445
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- RIFAMPIN
- RxCUI
- 312821
- SPL ID
- 2e65f8eb-0189-46db-9458-98ef7f67a156
- SPL set ID
- 8be91604-d7cd-4f2b-997d-e3364e4092e5
- Package NDC
- 67457-445-60
- Nui
- N0000175500, M0019113
- Pharm class epc
- Rifamycin Antibacterial [EPC]
- Pharm class cs
- Rifamycins [CS]
- UNII
- VJT6J7R4TR